KRISTA CELESTIN: Open Payments
NPI 1932599362 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 48 payments from 10 companies in 2025. Trend: 2023 $360 · 2024 $717 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $254 |
| AstraZeneca Pharmaceuticals LP | 6 | $163 |
| Novo Nordisk Inc | 13 | $159 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $83 |
| PFIZER INC. | 4 | $76 |
| Boston Scientific Corporation | 4 | $68 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Seqirus USA Inc | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
Products named: VRAYLAR, Ozempic, AIRSUPRA, JOURNAVX, NURTEC ODT, WaveWriter Alpha Prime 16, ZORYVE, FARXIGA.
Industry payments across CA — which companies pay providers there.
